国际麻醉学与复苏杂志   2024, Issue (8): 0-0
    
不同镇静方法用于儿童泌尿系统磁共振成像检查的回顾性研究
王少超, 王磊, 赵文, 昝云雷, 李全德, 林晓莉1()
1.山东大学附属儿童医院/济南市儿童医院
Application of different sedation methods for magnetic resonance imaging examination of the urinary system in children: a retrospective study
 全文:
摘要:

目的 探讨不同镇静方法用于儿童饮水后行泌尿系统磁共振成像(MRI)检查的有效性和安全性。 方法 以2021年1月1日至2022年11月31日在山东大学附属儿童医院镇静中心接受镇静行泌尿系统MRI检查的患儿为研究对象,通过检索电子病历系统和镇静管理系统收集患儿病历资料,按照镇静方法不同分为口服咪达唑仑+右美托咪定滴鼻组(PO组)和静脉注射咪达唑仑+丙泊酚组(IV组)。采用倾向性评分对相关变量进行匹配,成功匹配到88对,比较两组患儿一般资料[性别、年龄、体重、美国麻醉医师协会(ASA)分级]、一次镇静成功率、入睡时间、苏醒时间、检查时间及不良反应发生情况,统计并分析用药前(T0)、入睡后即刻(T1)、检查开始时(T2)及苏醒后即刻(T3)的心率、脉搏血氧饱和度(SpO2)和呼吸频率(RR)。 结果 倾向性评分匹配后,两组患儿性别、年龄、体重、ASA分级、一次镇静成功率及检查时间比较,差异均无统计学意义(均P>0.05)。PO组入睡时间和苏醒时间均长于IV组(均P<0.05)。VI组T3时心率明显低于PO组(P<0.05),各时点RR均低于PO组(均P<0.05);两组患儿各时点SpO2差异无统计学意义(均P>0.05)。与T0时比较,T1~T3时两组心率、SpO2和RR均降低,除IV组T3时的RR外差异均有统计学意义(均P<0.05);与T1时比较,T3时PO组SpO2、RR及IV组RR均升高(均P<0.05);与T2时比较,T3时两组患儿RR均升高(均P<0.05)。所有患儿均顺利完成MRI检查,PO组出现4例心率下降和1例苏醒期烦躁,IV组有1例心率下降,两组患儿不良反应发生情况比较差异无统计学意义(均P>0.05)。 结论 口服咪达唑仑联合右美托咪定滴鼻镇静和静脉注射咪达唑仑联合丙泊酚镇静两种方法用于儿童饮水后行泌尿系统MRI检查均安全有效,成功率高,不良反应少,未发生反流误吸情况。

关键词: 镇静; 儿童; 咪达唑仑; 右美托咪定; 丙泊酚; 磁共振成像
Abstract:

Objective To investigate the effectiveness and safety of different sedation methods for magnetic resonance imaging (MRI) examination of the urinary system in children after drinking water. Methods Children who received sedative treatment for urological MRI examination at the Sedation Center of Children's Hospital Affiliated to Shandong University from January 1, 2021 to November 31, 2022 were selected as subjects. Their medical records were collected by retrieving the electronic medical record system and the sedation management system. According to their corresponding sedation methods, the children were divided into two groups: an oral midazolam + dexmedetomidine nasal drip group (group PO) and an intravenous midazolam+propofol group (group IV). The propensity score was used to match the relevant variables, and 88 pairs were successfully matched. Both groups were compared for general information [gender, age, weight, and American Society of Anesthesiologists (ASA) grades], the success rate of one-time sedation, the time to fall asleep, the time to awaken, the duration of examination, and the incidence of adverse reactions. Heart rate, pulse oxygen saturation (SpO2) and respiratory rate (RR) were analyzed before medication (T0), immediately after sleep (T1), at the beginning of examination (T2) and immediately after awakening (T3). Results After propensity score matching, there were no statistical differences in gender, age, weight, ASA grade, the success rate of one-time sedation, and the duration of examination between the two groups (all P>0.05). Group PO showed significantly longer time to fall asleep and awaken than group IV (all P<0.05). Group VI also presented significantly lower heart rate than group PO at T3 (P<0.05), and lower RR than group PO at all the time points (all P<0.05). There were no statistical differences in SpO2 between the two groups at all the time points (all P>0.05). Compared with those at those at T0, both groups showed decreases in heart rate, SpO2 and RR at T1 to T3, and the differences were statistically significant except for RR in group IV at T3 (all P<0.05). Compared with those at T1, SpO2 and RR in group PO and RR in group IV increased at T3 (all P<0.05). Compared with those at T2, RR in both groups increased at T3 (all P<0.05). All the children successfully completed MRI examination, including four cases of decreased heart rate and one case of irritability during the awakening period in group PO, and one case of decreased heart rate in group IV, there was no significant difference in adverse reactions between the two groups (all P>0.05). Conclusions Both oral midazolam combined with dexmedetomidine nasal drip and intravenous midazolam combined with propofol are safe and effective for urinary MRI examination of the urinary system in children after drinking water, with a high success rate, fewer adverse reactions, and without reflux aspiration.

Key words: Sedation; Children; Midazolam; Dexmedetomidine; Propofol; Magnetic resonance imaging